Form 4: CalciMedica Chief Business Officer Boosts Stake with Share Purchase

Eric W. Roberts, CalciMedica's Chief Business Officer, Director, and 10% owner, acquired 6,500 shares of common stock, signaling increased insider confidence.

Summary

• Eric W. Roberts, Chief Business Officer, Director, and 10% owner of CalciMedica, Inc. (CALC), purchased 6,500 shares of the company's common stock.
• The transaction occurred on July 14, 2025.
• The shares were acquired at a weighted average price of $2.4323 per share, with prices ranging from $2.30 to $2.55.
• Following this transaction, Roberts beneficially owns 44,323 shares indirectly through an FMTC Custodian Roth IRA.
• Roberts also holds other indirect and direct beneficial ownerships, including 164,706 direct shares, 49,894 shares via Oppenheimer & Co Inc. Custodian, 10,661 shares via IRA Financial Trust Company, 356,989 shares via Valence Investments SPV IV, LLC, 66,228 shares via Valence Investments SPV V, LLC, and 316,109 shares via Valence Investments SPV VI, LLC.

Sentiment

Score: 8

Explanation: The purchase of shares by a high-ranking insider and significant owner like Eric W. Roberts typically signals strong confidence in the company's prospects, which is a positive indicator for investors.

Positives

• A key insider, Eric W. Roberts, who serves as Chief Business Officer, Director, and a 10% owner, purchased additional shares, indicating strong confidence in the company's future prospects.
• The acquisition of 6,500 shares at an average price of $2.4323 demonstrates a direct financial commitment from management.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The insider purchase may increase investor confidence and potentially positively influence stock perception.

Key Dates

Recommendation

Keywords

CalciMedica, CALC, SEC Form 4, insider trading, share purchase, common stock, Eric W. Roberts, Chief Business Officer, Director, 10% owner, beneficial ownership